Corrigendum to: Imaging and cancer: A review (Molecular Oncology, (2008), 2, 2, (115-152), 10.1016/j.molonc.2008.04.001);Imaging and cancer: A review

Molecular Oncology

Volumn 2, Issue 2, 2008, Pages 115-152

  Fass, Leonard ^a,b  

^a GE HEALTHCARE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Contrast; Diagnosis; Imaging; Staging; Therapy; Tracers

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ACETIC ACID C 11; BIOTIN; CAPROMAB PENDETIDE IN 111; CARBETIMER; CHOLINE C 11; CISPLATIN; COPPER 64; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FLUTAMIDE; GALLIUM 67; INDIUM 111; IODINE 123; IODINE 131; METOMIDATE; OXYGEN 15; PACLITAXEL; PENTETREOTIDE IN 111; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TAMOXIFEN; TECHNETIUM 99M; THALLIUM 201; TUMOR MARKER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNINDEXED DRUG; VOROZOLE; YTTRIUM 90;

ANGIOGENESIS; APOPTOSIS; BLOOD FLOW; BONE METASTASIS; BRAIN CANCER; BREAST CANCER; CANCER RECURRENCE; CANCER RESEARCH; CANCER SCREENING; CANCER SIZE; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COMPUTER ASSISTED IMPEDANCE TOMOGRAPHY; COMPUTER ASSISTED RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DIGITAL MAMMOGRAPHY; DIGITAL RADIOGRAPHY; DNA DETERMINATION; DRUG HALF LIFE; DRUG UPTAKE; ELASTOGRAPHY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HYPOXIA; IMAGE RECONSTRUCTION; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; LUNG CANCER; MICROFLUIDIC ANALYSIS; MULTIDRUG RESISTANCE; NEOPLASM; NEUROENDOCRINE TUMOR; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL TOMOGRAPHY; PHOTOACOUSTIC SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SYNTHESIS; REVIEW; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STEM CELL; THORAX RADIOGRAPHY; X RAY;

EID: 46849085176     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1002/1878-0261.13283     Document Type: Erratum

References (439)

1. Aberg P., Nicander I., Hansson J., Geladi P., Holmgren U., and Ollmar S. Skin cancer identification using multifrequency electrical impedance - a potential screening tool. IEEE Transactions on Biomedical Engineering 51 (2004) 2097-2102
2. Aboagye E.O., and Bhujwalla Z.M. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Research 59 (1999) 80-84
3. 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma I tumours. Cancer Research 58 (1998) 1063-1067
4. Abourbeh G., Dissoki S., Jacobson O., et al. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. Nuclear Medicine and Biology 34 (2007) 55-70
5. Albertoni P. Novel antitenascin antibody with increased tumour localisation for pretargeted antibody-guided radioimmunotherapy (PAGRIT). British Journal of Cancer 88 (2003) 996-1003
6. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). fourth ed. (2004), American College of Radiology, Reston, VA
7. Anderson H.L., Yap J.T., Miller M.P., et al. Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. Journal of Clinical Oncology 21 (2003) 2823-2830
8. Anwer K., et al. Ultrasound enhancement of cationic lipid mediated gene transfer to primary tumors following systemic administration. Gene Therapy 7 (2000) 1833-1839
9. Ardenkjaer-Larsen J.H., et al. Increase in signal-to noise ratio of >10,000 times in liquid-state NMR. Proceedings of the National Academy of Sciences USA 100 (2003) 10158-10163
10. Artemov D., Mori N., Okollie B., and Bhujwalla Z.M. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magnetic Resonance in Medicine 49 (2003) 403-408
11. Ashamalla H., Rafla S., Parikh K., Mokhtar B., Goswami G., Kambam S., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. International Journal of Radiation Oncology Biology Physics 63 (2005) 1016-1023
12. Atri M. New technologies and directed agents for applications of cancer imaging. Journal of Clinical Oncology 24 20 (2006) 3299-3308
13. Backer M.V., et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nature Medicine 13 (2007) 504-509
14. Bae U., et al. Ultrasound thyroid elastography using carotid artery pulsation. Journal of Ultrasound in Medicine 26 (2007) 797-805
15. Balamugesh T., et al. Empyema - a rare complication of transbronchial lung biopsy. Respiratory Medicine Extra 1 3 (2005) 97-99
16. 1H) MR spectroscopy of the breast. RadioGraphics 27 (2007) S241-S252
17. 1H) MR spectroscopy. Radiology 245 (2007) 80-87
18. 18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Research 63 (2003) 3791-3798
19. Bauer W., Claudia C., and Langer O. Microdosing studies in humans: the role of positron emission tomography. Drugs in R & D 9 2 (2008) 73-81
20. Bayford R.H. Bioimpedance tomography (electrical impedance tomography). Annual Review of Biomedical Engineering 8 (2006) 63-91
21. 18F-FAZA predicts success of hypoxia directed radiochemotherapy using tirapazamine. Journal of Nuclear Medicine 48 6 (2007) 973-980
22. 18Fgalacto- RGD, a new radiotracer for imaging alpha v beta3 expression. Journal of Nuclear Medicine 47 (2006) 763-769
23. 18F]Fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 34 8 (2007) 1316-1317
24. Belfiore G., Tedeschi E., Moggio G., Coffi R., Cincotti F.C., and Rossi R. CT-guided radiofrequency palliative ablation of unresectable lung cancer: clinical and imaging findings at one-year follow-up. Radiology 233 (2004) 513 abstract SSK05-06
25. Belhocine T.Z., et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. Journal of Nuclear Medicine 47 (2006) 957-967
26. Bergers G., and Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology 7 4 (2005) 452-464
27. Bergland A., et al. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. Journal of Internal Medicine 249 3 (2001) 247-251
28. Bergstrom M., Grahnen A., and Langstrom B. Positron emission tomography microdosing: A new concept with application in tracer and early clinical drug development. European Journal of Clinical Pharmacology 59 (2003) 357-366
29. Bertino Jr. J.S., Greenberg H.E., and Reed M.D. American College of Clinical Pharmacology Position Statement on the Use of Microdosing in the Drug Development Process. Journal of Clinical Pharmacology 47 4 (2007) 418-422
30. Beyer T., Townsend D.W., and Blodgett T.M. Dual-modality PET/CT tomography for clinical oncology. Quarterly Journal of Nuclear Medicine 46 (2002) 24-34
31. Bhattacharyya M., et al. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. British Journal of Cancer 98 (2008) 289-293
32. Blana A., Walter B., Rogenhofer S., and Wieland W.F. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63 (2004) 297-300
33. Boddy A.V., et al. Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia. Clinical Cancer Research 13 (2007) 4164-4169
34. Bohndiek S.E., et al. A CMOS active pixel sensor system for laboratory-based x-ray diffraction studies of biological tissue. Physics in Medicine and Biology 53 (2008) 655-672
35. Bolster J.M., Vaalburg W., Paans A.M., et al. Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET). European Journal of Nuclear Medicine 12 (1986) 321-324
36. Brasch R., and Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. European Journal of Radiology 34 (2000) 148-155
37. Brem R.F., Rapelyea J.A., Zisman G., et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology 237 1 (2005) 274-280
38. Brem R.F., et al. Breast-specific gamma imaging with 99mTc-sestamibi and magnetic resonance imaging in the diagnosis of breast cancer: a comparative study. Breast Journal 13 5 (2007) 465-469
39. Brenner D.J., Elliston C.D., Hall E.J., et al. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatric Radiology 32 (2002) 228-231
40. Brindle K.M. Molecular imaging using magnetic resonance: new tools for the development of tumour therapy. British Journal of Radiology 76 (2003) S111-S117
41. Brindle K. New approaches for imaging tumour responses to treatment. Nature Reviews Cancer 8 (2008) 94-107
42. 18F]FDG-PET on the primary staging of small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging 31 (2004) 1614-1620
43. 18F-FDG PET/CT examinations. Journal of Nuclear Medicine 46 (2005) 608-613
44. Buadu L.D., et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200 (1996) 639-649
45. Buckley D.L., et al. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. Journal of Magnetic Resonance Imaging 7 (1997) 461-464
46. Buijs M., et al. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. Journal of Vascular and Interventional Radiology 18 8 (2007) 957-963
47. Burnside E., et al. Differentiating benign from malignant solid breast masses with US strain imaging. Radiology 245 2 (2007) 401-410
48. Buzug T.M., et al. MRI based attenuation correction for brain PET images. Advances in Medical Imaging 114 (2007) 93-97
49. 18F-FDG PET/CT in pediatric oncology. Journal of Nuclear Medicine 48 suppl. 2 (2007) 118 abstract
50. Cai W., et al. PET of vascular endothelial growth factor receptor expression. Journal of Nuclear Medicine 47 (2006) 2048-2056
51. Campadelli P., Casiraghi I., and Artioli D.A. Fully automated method for lung nodule detection from postero-anterior chest radiographs. Medical Imaging 25 12 (2006) 1588-1603
52. Carrino J.A., and Jolesz F.A. MRI-guided interventions. Academic Radiology 12 (2005) 1063-1064
53. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. Journal of Nuclear Medicine 47 8 (2006) 1241-1248
54. Catane R., et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases - preliminary clinical experience. Annals of Oncology 18 (2007) 163-167
55. Chan W.C., Maxwell D.J., Gao X., Bailey R.E., Han M., and Nie S. Luminescent quantum dots for multiplexed biological detection and imaging Current Opinion in Biotechnology 13 (2002) 40-46
56. 18F-FDG. Journal of Nuclear Medicine 46 6 (2005) 945-952
57. 18F labeled PEGylated RGD peptide. European Journal of Nuclear Medicine and Molecular Imaging 31 8 (2004) 1081-1089
58. 64Cu-labeled dimeric RGD peptides. Molecular Imaging and Biology 6 5 (2004) 350-359
59. Chen X., et al. Pharmacokinetics and tumor retention of (125)I-labeled RGD peptide are improved by PEGylation. Nuclear Medicine and Biology 31 1 (2004) 11-19
60. Chen X., Plasencia C., Hou Y., et al. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. Journal of Medicinal Chemistry 48 (2005) 1098-1106
61. Chenevert T.L., Stegman L.D., Taylor J.M.G., Robertson P.L., Greenberg H.S., Rehemtulla A., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. Journal of the National Cancer Institute 92 (2000) 2029-2036
62. Cherepenin V., et al. A 3D electrical impedance tomography (EIT) system for breast cancer detection. Physiological Measurement 22 (2001) 9-18
63. Ciernik I.F., Dizendorf E., Baumert B.G., Reiner B., Burger C., Davis J.B., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. International Journal of Radiation Oncology Biology Physics 57 (2003) 853-863
64. Civelek A.C., et al. Tc-99m sestamibi uptake in the chest mimicking a malignant lesion of the breast. The Breast 15 1 (2006) 111-114
65. Cohen A., et al. Monitoring of chemotherapy induced cell death in melanoma tumors by N,N′-didansyl-l-cystine. Technology in Cancer Research & Treatment 6 3 (2007) 221-234
66. Coover L.R., Caravaglia G., Kunh P., et al. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. Journal of Nuclear Medicine 45 4 (2004) 553-558
67. Czernin J., Weber W.A., and Herschman H.R. Molecular imaging in the development of cancer therapeutics. Annual Reviews of Medicine 57 (2006) 99-118
68. Damadian R. Tumor detection by nuclear magnetic resonance. Science 171 (1971) 1151-1153
69. 13C magnetic resonance imaging and spectroscopy. Nature Medicine 13 (2007) 1382-1387
70. De Boer R.J., et al. Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. European Journal of Nuclear Medicine 29 (2002) 1182-1187
71. 18F-FDG PET in patients with non-small cell lung cancer. Journal of Nuclear Medicine 48 10 (2007) 1592-1598
72. de Geus-Oei L.F., et al. Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer. Annals of Oncology 19 2 (2008) 348-352
73. de Torres J.P., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 132 (2007) 1932-1938
74. Dehdashti F., et al. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. Journal of Nuclear Medicine 36 10 (1995) 1766-1772
75. Dehdashti F., et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 32 3 (2005) 344-350
76. Dehghani H., Pogue P.W., Poplack S.P., and Paulsen K.D. Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results. Applied Optics 42 (2003) 135-145
77. Dekker B., Keen H., Lyons S., et al. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET. Nuclear Medicine and Biology 32 (2005) 241-252
78. D'Hallewin M.A., El Khatib S., Leroux A., Bezdetnaya L., and Guillemin F. Endoscopic confocal fluorescence microscopy of normal and tumor bearing rat bladder. Journal of Urology 174 2 (2005) 736-740
79. Diekmann F., and Bick U. Tomosynthesis and contrast-enhanced digital mammography; recent advances in digital mammography. European Radiology 17 12 (2007) 3086-3092
80. Dobbins J.T., et al. Digital x-ray tomosynthesis: current state of the art and clinical potential. Physics in Medicine and Biology 48 (2003) R65-R106
81. Downey R.J., Akhurst T., Ilson D., et al. Whole body18-F FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. Journal of Clinical Oncology 21 (2003) 428-432
82. Downey R.J., Akhurst T., Gonen M., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. Journal of Clinical Oncology 22 (2004) 3255-3260
83. Dromi S., et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and anti-tumor effect. Clinical Cancer Research 13 9 (2007) 2722-2727
84. Dugdale P.E., Miles K.A., Bunce I., Kelley B.B., and Leggett D.A.C. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. Journal of Computer Assisted Tomography 23 4 (1999) 540-547
85. Ehman R.L., et al. Blueprint for imaging in biomedical research. Radiology 244 1 (2007) 12
86. Enquobahrie A.A., et al. Automated detection of small pulmonary nodules in whole lung CT scans. Academic Radiology 14 5 (2007) 579-593
87. Eriksson B., et al. The role of PET in localization of neuroendocrine and adrenocortical tumors. Annals of the New York Academy of Sciences 970 (2002) 159-169
88. 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. Journal of Nuclear Medicine 46 (2005) 253-260
89. European Agency for the Evaluation of Medicinal Products. Evaluation of Medicines for Human Use. Position Paper on Non-Clinical Safety Studies to Support Clinical Trials with a Single Microdose (2003), EMEA, London pp. 1-4
90. 18F EF5 PET imaging with immunohistochemical validation in patients with brain lesions. International Journal of Radiation Oncology Biology Physics 66 3 (2006) S248
91. Even-Sapir E., et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. Journal of Nuclear Medicine 44 9 (2003) 1413-1420
92. Fahey B.J., et al. Liver ablation guidance with acoustic radiation force impulse imaging: challenges and opportunities. Physics in Medicine and Biology 51 (2006) 3785-3808
93. Fahey B.J., et al. In vivo visualization of abdominal malignancies with acoustic radiation force elastography. Physics in Medicine and Biology 53 (2008) 279-293
94. 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis. AntiCancer Research 26 1A (2006) 431-434
95. Fermé C., et al. Role of imaging to choose treatment. Cancer Imaging 5 (2005) S113-S119
96. Fogelman I., et al. Positron emission tomography and bone metastases. Seminars in Nuclear Medicine 35 2 (2005) 135-142
97. Folkman J. The role of angiogenesis in tumor growth. Seminars in Cancer Biology 3 (1992) 65-71
98. Fournier L., et al. Dynamic contrast-enhanced CT (DCE-CT) as an early biomarker of response in metastatic renal cell carcinoma (mRCC) under anti-angiogenic treatment. 2007 ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 25 18S (2007) (abstract 14003)
99. Franceschini M.A., et al. Frequency-domain techniques enhance optical mammography: initial clinical results. Proceedings of the National Academy of Sciences USA 94 (1997) 6468-6473
100. Frank R., and Hargreaves R. Clinical biomarkers in drug discovery and development. Nature Reviews Drug Discovery 2 7 (2003) 566-580
101. 67Ga scintigraphy. Radiology 214 (2000) 253-257
102. Frush D.P., Donnelly L.F., and Rosen N.S. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics 112 (2003) 951-957
103. Furtado C.D., et al. Whole body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology 237 2 (2005) 385-394
104. Furusawa H., Namba K., Thomasen S., Akiyama F., Bendet A., Tanaka C., Yasuda Y., and Nakahara H. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. Journal of the American College of Surgeons 203 1 (2006) 54-63
105. Gangi A., et al. Injection of alcohol into bone metastases under CT guidance. Journal of Computer Assisted Tomography 18 (1994) 932-935
106. Gao X., Yang L., Petros J.A., et al. In vivo molecular and cellular imaging with quantum dots. Current Opinion in Biotechnology 16 (2005) 63-72
107. Gao Z, et al. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics, in press.
108. GE Senographe, 1999. 2000D FDA PMA submission P990066.
109. Geddes L.A., and Baker L.E. The specific resistance of biological materials: a compendium of data for the biomedical engineer and physiologist. Medical and Biological Engineering 5 (1967) 271-293
110. Getty D, et al. 2007. Improved accuracy of lesion detection in breast cancer screening with stereoscopic digital mammography. RSNA Meeting 2007 (abstract SSG01-04).
111. Ghandi S., et al. Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma. Clinical Radiology 61 10 (2006) 888-891
112. Gianfelice D., Khiat A., Boulanger Y., et al. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. Journal of Vascular and Interventional Radiology 14 (2003) 1275-1282
113. Gilkeson R.C., and Sachs P.B. Dual energy subtraction digital radiography: technical considerations, clinical applications, and imaging pitfalls. classic concepts in thoracic imaging. Journal of Thoracic Imaging 21 4 (2006) 303-313
114. Gillies R.J., and Morse D.L. In vivo magnetic resonance spectroscopy in cancer. Annual Review of Biomedical Bioengineering 7 (2005) 287-326
115. Gillies J.M., et al. Microfluidic technology for PET radiochemistry. Applied Radiation and Isotopes 64 3 (2006) 333-336
116. 13N]Cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. Journal of Nuclear Medicine 28 (1987) 1844-1852
117. Goel M, et al., 2006. Application of near infrared multi-spectral CCD imager system to determine the hemodynamic changes in prostate tumor. OSA Biomedical Topical Meetings: SH10, Fort Lauderdale, FL.
118. Golman K., and Petersson J.S. Metabolic imaging and other applications of hyperpolarized 13C. Academic Radiology 13 (2006) 932-942
119. 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Research 66 (2006) 10855-10860
120. Golman K., Zandt R.I., and Thaning M. Real-time metabolic imaging. Proceedings of the National Academy of Sciences USA 103 (2006) 11270-11275
121. Grazioso R., et al. APD-based PET detector for simultaneous PET/MR imaging. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers. Detectors and Associated Equipment 569 2 (2006) 301-305
122. Gromet M. Comparison of computer-aided detection to double reading of screening mammograms: review of 231,221 mammograms. AJR American Journal of Roentgenology 190 4 (2008) 854-859
123. 18F]FMISO in an experimental mammary carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 31 4 (2004) 513-520
124. Grosenick D., et al. Development of a time domain optical mammograph and first in vivo applications. Applied Optics 38 (1999) 2927-2943
125. 18F-FAZA-PET for dose painting using intensity modulated radiotherapy in patients with head and neck cancer. International Journal of Radiation Oncology Biology Physics 63 Suppl 1 (2005) S132-S133
126. Gu X., et al. Differentiation of cysts from solid tumors in the breast with diffuse optical tomography. Academic Radiology 11 1 (2004) 2094-2107
127. Gupta N., Price P.M., and Aboagye E.O. PET for in vivo pharmacokinetic and pharmacodynamic measurements. European Journal of Cancer 38 (2002) 2094-2107
128. Gusev V.E., and Karabutov A.A. Laser Optoacoustics (1993), American Institute of Physics
129. Haider M.A., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR American Journal of Roentgenology 189 (2000) 323-328
130. Hainfeld J.F., Slatkin D.N., Focella T.M., and Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. British Journal of Radiology 79 (2006) 248-253
131. Halter R, Hatrov A, Paulsen KD. High frequency EIT for breast imaging. Sixth Conference on Biomedical Application of Electrical Impedance Tomography, London, UK (2005).
132. Halter R.J., Hartov A., and Paulsen K.D. A broadband high-frequency electrical impedance tomography system for breast imaging. IEEE Transactions on Biomedical Engineering 55 2 (2008) 650-659
133. Harishingani M.G., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New England Journal of Medicine 348 (2003) 2491-2499
134. Hayashi K., et al. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovascular and Interventional Radiology 30 (2007) 1144-1155
135. He W., Wang H.F., Hartmann L.C., Cheng J.X., and Low P.S. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proceedings of the National Academy of Sciences USA 104 (2007) 11760-11765
136. Hehenberger M., et al. IT solutions for imaging biomarkers in biopharmaceutical research and development. Information-Based Medicine 46 1 (2007) 183-198
137. Heilbrun M.E., et al. CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR American Journal of Roentgenology 188 6 (2007) 1500-1505
138. Helbich T.H., Roberts T.P., Gossmann A., et al. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magnetic Resonance in Medicine 44 (2000) 915-924
139. Hellstrom M., Svensson M.H., and Lasson A. Extracolonic and incidental findings on CT colonography (virtual colonoscopy). AJR American Journal of Roentgenology 182 3 (2004) 631-638
140. Hendrikse N.H., and Vaalburg W. Dynamics of multidrug resistance: P-glycoprotein analyses with positron emission tomography. Methods 27 3 (2002) 228-233
141. 11C]Metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. Journal of Clinical Endocrinology and Metabolism 91 4 (2006) 1410-1414
142. Henschke C.I., Yankelevitz D.F., Libby D.M., Pasmantier M.W., and Smith J.P. Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. New England Journal of Medicine 355 17 (2006) 1763-1771
143. Henschke C.I., et al. Survival of patients with clinical stage I lung cancer diagnosed by computed tomography screening for lung cancer. Clinical Cancer Research 13 17 (2007) 4949-4950
144. Henschke C.I. Computed tomography screening for lung cancer. JAMA 298 5 (2007) 514-515
145. Herbst R.S., Mullani N.A., Davis D.W., et al. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. Journal of Clinical Oncology 20 (2002) 3804-3814
146. 18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma. Clinical Cancer Research 13 12 (2007) 3552-3558
147. Hillman B.J. Introduction to the Special Issue on Medical Imaging in Oncology. Journal of Clinical Oncology 24 20 (2006) 3223-3224
148. Hillner B.E., et al. The National Oncologic PET Registry (NOPR): design and analysis plan. Journal of Nuclear Medicine 48 11 (2007) 1901-1908
149. Hindley J., Gedroyc W.M., Regan L., et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR American Journal Roentgenology 183 (2004) 1713-1719
150. Hirsch L.R., Halas N.J., and West J.L. Nanoshell-mediated near- infrared thermal therapy of tumors under magnetic resonance guidance. Proceedings of the National Academy of Sciences USA 100 (2003) 13549-13554
151. 11C-acetate imaging in hepatocellular carcinoma and other liver masses. Nuclear Medicine 44 2 (2003) 213-221
152. Hofmann M., et al. MR-based PET attenuation correction: method and validation. Proceedings of the 2007 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS-MIC 2007), 6 (2007), IEEE Computer Society, Los Alamitos, CA, USA
153. Holdsworth C.H., et al. CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR American Journal of Roentgenology 189 (2007) W324-W330
154. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. Journal of Magnetic Resonance Imaging 20 (2004) 654-661
155. Hricak H. MRI and choline-PET of the prostate, Refresher Course 88 Deutsche RoentgenKongress. Fortschritte der Röntgenstrahlen 179 Suppl. (2007)
156. Huang S.C. Anatomy of SUV. Nuclear Medicine and Biology 27 (2000) 643-646
157. Hui Z., et al. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. Journal Ultrasound in Medicine 26 (2007) 807-815
158. Hung S.C., et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clinical Cancer Research 11 21 (2005) 7749-7756
159. 18F]-choline PET/CT for staging and restaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 35 2 (2008) 253-263
160. Hynynen K., et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24 1 (2005) 12-20
161. Iinuma G., Ushio K., Ishikawa T., Nawano S., Sekiguchi R., and Satake M. Diagnosis of gastric cancers comparison of conventional radiography with a 4 million-pixel charge coupled device. Radiology 214 2 (2000) 497
162. 131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. Journal of Clinical Endocrinology & Metabolism 88 9 (2003) 4083-4087
163. 18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study. Cancer Biotherapy & Radiopharmaceuticals 11 (1996) 235-245
164. Intenzo C.M., et al. Scintigraphic imaging of body neuroendocrine tumors. Radiographics 27 (2007) 1355-1369
165. Intes X. Time-domain optical mammography SoftScan: initial results. Academic Radiology 12 8 (2005) 934-947 (erratum 12(10), 1355)
166. Itoh A., Ueno E., Tohno E., et al. Breast disease: clinical application of US elastography for diagnosis. Radiology 239 (2006) 341-350
167. Itoh J., and Osamura R.Y. Quantum dots for multicolor tumor pathology and multispectral imaging. Methods in Molecular Biology 374 (2007) 29-42
168. 11C-methyl-methionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine 46 (2005) 1948-1958
169. Jager P.L., Vaalburg W., Pruim J., de Vries E.G., Langen K.J., and Piers D.A. Radiolabeled amino acids: basic aspects and clinical applications in oncology. Journal of Nuclear Medicine 42 3 (2001) 432-445
170. Jain M., and Batra S.K. Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis. Journal of Nuclear Medicine 44 12 (2003) 1970
171. 13C NMR: a simple yet comprehensive method for analysis of intermediary metabolism. Trends in Biochemical Sciences 16 (1991) 5-10
172. Jennewein M., et al. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clinical Cancer Research 14 (2008) 1377-1385
173. Jensch S., et al. CT colonography with limited bowel preparation: performance characteristics in an increased-risk population. Radiology 247 1 (2008) 122-132
174. Joines W.T., Zhang Y., Li C., and Jirtle R.L. The measured electrical properties of normal and malignant tissues from 50 to 900 MHz. Medical Physics 21 (1994) 547-550
175. Jolesz F.A., and Hynynen K. Magnetic resonance image-guided focused ultrasound surgery. Cancer Journal 8 (2002) S100-S112
176. Jolesz F.A., Hynynen K., McDannold N., and Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive image guided surgery. Magnetic Resonance Imaging Clinics of North America 13 (2006) 545-560
177. Jong R.A. Contrast-enhanced digital mammography: initial clinical experience. Radiology 228 3 (2003) 842-850
178. 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy. Journal of Nuclear Medicine 47 12 (2006) 2000-2007
179. Juweid M.E., Wiseman G.A., Vose J.M., et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. Journal of Clinical Oncology 23 (2005) 4652-4661
180. Kamat P.P., et al. Hepatic embolization in patients with liver metastases. Cardiovascular and Interventional Radiology 31 2 (2008) 299-307
181. Kao T.J., et al. A compensated radiolucent electrode array for combined EIT and mammography. Physiological Measurement 28 7 (2007) S291-S299
182. Kao T.J., Isaacson D., Newell J.C., and Saulnier G.J. A 3D reconstruction algorithm for EIT using a handheld probe for breast cancer detection. Physiological Measurement 27 5 (2006) S1-S11
183. 11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 29 11 (2002) 1492-1495
184. Kato H., Fukuchi M., Miyazaki T., et al. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography. AntiCancer Research 27 (2007) 2627-2633
185. Kazuhiro P., et al. Classifying pulmonary nodules using dynamic enhanced CT images. IEIC Technical Report (Institute of Electronics, Information and Communication Engineers) 106 105 (2006) 39-43
186. 124I-annexin V and PET. Nuclear Medicine and Biology 32 (2005) 395-402
187. Keidar Z., Haim N., Guralnik L., Wollner M., Bar-Shalom R., Ben-Nun A., et al. PET/CT using FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. Journal of Nuclear Medicine 45 (2004) 1640-1646
188. Kemper J., et al. MR elastography of the prostate: initial in-vivo application. Rofo 176 8 (2004) 1094-1099
189. Kenis H., et al. Annexin A5: shifting from a diagnostic towards a therapeutic realm. Cellular and Molecular Life Sciences 64 22 (2007) 2859-2862
190. Kent M.S., Port J.L., and Altorki N.K. Current state of imaging for lung cancer staging. Thoracic Surgery Clinics 14 (2004) 1-13
191. Khalkhali I., Baum J.K., Villanueva-Meyer J., et al. (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology 222 1 (2002) 149-155
192. Kim S.J., et al. Computer-aided detection in full-field digital mammography sensitivity and reproducibility in serial examinations. Radiology 246 1 (2008) 71-79
193. Kim Y., et al. Multiphase contrast-enhanced CT imaging in hepatocellular carcinoma correlation with immunohistochemical angiogenic activities. Academic Radiology 14 9 (2007) 1084-1091
194. Kinoshita M. Targeted drug delivery to the brain using focused ultrasound. Topics in Magnetic Resonance Imaging 17 3 (2006) 209-215
195. Kircher M.F., Mahmood U., King R.S., Weissleder R., and Josephson L.A. Multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Research 63 (2003) 8122-8125
196. Kiss G., Van Cleynenbreugel J., Thomeer M., Suetens P., and Marchal G. Computer aided diagnosis for virtual colonography. MICCAI, Utrecht, The Netherlands. Lecture Notes in Computer Science (2001) 2208: 621
197. 18F] fluoromisonidazole. International Journal of Radiation Oncology Biology Physics 22 (1992) 199-212
198. Kolb T.M., et al. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225 (2002) 165-175
199. Kopelman D., Inbar Y., Hanannel A., Dank G., Freundlich D., Perel A., Castel D., Greenfeld A., Salomon T., Sareli M., Valeanu A., and Papa M. Magnetic resonance-guided focused ultrasound surgery (MRgFUS): four ablation treatments of a single canine hepatocellular adenoma. HPB 8 (2006) 292-298
200. 90Y-DOTATOC therapy. European Journal of Nuclear Medicine and Molecular Imaging 33 4 (2006) 460-466
201. Kruger R.A., Miller K.D., Reynolds H.E., Kiser Jr. W.L., Reinecke D.R., and Kruger G.A. Contrast enhancement of breast cancer in vivo using thermoacoustic CT at 434 MHz. Radiology 216 (2000) 279-283
202. Kruse S.A., Smith J.A., Lawrence A.J., et al. Tissue characterization using magnetic resonance elastography: preliminary results. Physics in Medicine and Biology 45 (2000) 1579-1590
203. 11C]]methionine. Japanese Journal of Cancer Research 80 (1989) 778-782
204. Kuhl C.K., Mielcareck P., Klaschik S., et al. Are signal time course data useful for differential diagnosis of enhancing lesions in dynamic breast MR imaging?. Radiology 211 1 (1999) 101-110
205. Kumar R., and Shamim S.A. Radiolabeled metaiodobenzylguanidine (MIBG) in the diagnosis and treatment of neural crest tumors. Journal of the Academy of Hospital Administration 16 2 (2004) 7-12
206. Kumar S., et al. Biomarkers in cancer screening, research and detection: present and future: a review. Biomarkers 11 5 (2006) 385-405
207. 18F-paclitaxel in nonhuman primates. Journal of Nuclear Medicine 44 (2003) 1330-1339
208. Kurhanewicz J., et al. Three dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2 1-2 (2000) 166-189
209. Kushner B.H., et al. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy. Journal of Clinical Oncology 21 6 (2003) 1082-1086
210. Kwan A.L.C., et al. In: Flynn M.J. (Ed). Medical Imaging 2005: Physics of Medical Imaging. Proceedings of the SPIE vol. 5745 (2005) 1317-1321
211. 11C]Carbon monoxide, a versatile and useful precursor in labelling chemistry for PET-ligand development. Journal of Labelled Compounds and Radiopharmaceuticals 50 9-10 (2007) 794-810
212. Larsen S.S., et al. Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Lung Cancer 48 1 (2005) 85-92
213. Larson S.M., Erdi Y., Akhurst T., et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging, the visual response score and the change in total lesion glycolysis. Clinical Positron Imaging 2 (1999) 159-171
214. Larson S.S., et al. Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management. Thorax 57 (2002) 98-103
215. Lauterbur P.C. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242 (1973) 190-191
216. Le Bihan D., Breton E., and Syrota A. Imagerie de diffusion par resonance magnetique nucleaire. Les Comptes rendus de l'Académie des sciences 301 (1985) 1109-1112
217. Leach M.O. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Research 3 (2001) 22-27
218. Lee K.S., Jeong Y.J., Han J., Kim B.T., Kim H., and Kwon O.J. T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. Radiographics 24 (2004) 1617-1636
219. Lehman C.D., et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244 2 (2007) 381-388
220. Lehtio K., Oikonen V., Gronroos T., et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and[(18)F]fluoroerythronitroimidazole PET. Journal of Nuclear Medicine 42 (2001) 1643-1652
221. 18F]FETNIM) and PET using the tumour to plasma ratio. European Journal of Nuclear Medicine Molecular Imaging 30 1 (2003) 101-108
222. Lerman H., et al. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. Journal of Nuclear Medicine 48 2 (2007) 201-206
223. Lerner R.M., Huang S.R., and Parker K.J. "Sonoelasticity" images derived from ultrasound signals in mechanically vibrated tissues. Ultrasound in Medicine & Biology 16 (1990) 231-239
224. 11C-colchicine for PET imaging of multiple drug resistance. Journal of Nuclear Medicine 41 (2000) 493-501
225. Lewin J.M., et al. Dual-energy contrast enhanced digital subtraction mammography: feasibility. Radiology 229 1 (2003) 261
226. Li H., Dai H., Xing L., and Sinclair R. Characterization of AuFe-C core-shell nanoparticles. Microscopy and Microanalysis 12 (2006) 524-525
227. Li K.C.P., Pandit S.D., Guccione S., and Bednarski M.D. Molecular imaging applications in nanomedicine. Biomedical Microdevices 6 (2004) 113-116
228. Liapi E., et al. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastases treated with transcatheter arterial chemoembolization. AJR American Journal of Roentgenology 190 1 (2008) 67-73
229. Liberman L., Mason G., Morris E.A., et al. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR American Journal of Roentgenology 186 2 (2006) 426-430
230. Linden H.M., et al. Monitoring targeted therapy: is fluorodeoxyglucose uptake a marker of early response?. Clinical Cancer Research 12 19 (2006) 5608-5610
231. Linden H.M., Stekhova S.A., Link J.M., et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. Journal of Clinical Oncology 24 (2006) 2793-2799
232. Liu J., Levine A., Mattoon J., Yamaguchi M., Lee R., Pan X., and Rosol T.J. Nanoparticles as image enhancing agents for ultrasonography. Physics in Medicine and Biology 51 (2006) 2179-2189
233. Liu J., Li J., Rosol T.J., Pan X., and Voorhees J.L. Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Physics in Medicine and Biology 52 (2007) 4739-4747
234. Liu S. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer. Bioconjugate Chemistry 18 2 (2007) 438-446
235. Liu Y., and Wang H. Nanotechnology tackles tumours. Nature Nanotechnology 2 1 (2007) 20-21
236. Lo W.K., van Sonnenberg E., Shankar S., Morrison P.R., Silverman S.G., Tuncali K., and Rabin M. Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. Journal of Vascular and Interventional Radiology 17 (2006) 175-179
237. Lorenz A., et al. Ultrasound elastography of the prostate. A new technique for tumor detection. Ultraschall in der Medizin 21 1 (2000) 8-15
238. 111In radiolabels. Journal of Nuclear Medicine 42 8 (2001) 1281-1286
239. Luo J., et al. Elasticity reconstruction for ultrasound elastography using a radial compression: an inverse approach. Ultrasonics 44 Suppl. 1 (2006) e195-e198
240. 18F]FLT). Journal of Radioanalytical and Nuclear Chemistry.,243 (2000) 843-846
241. MacMahon H. Dual-energy and temporal subtraction digital chest radiography. In: Samei E., and Flynn M.J. (Eds). Syllabus: Advances in Digital Radiography: RSNA Categorical Course in Diagnostic Radiology Physics (2003), RSNA Publications 181-188
242. Manohar S., Kharine A., van Hespen J.C.G., Steenbergen W., and van Leeuven T.G. The Twente photoacoustic mammoscope: system overview and performance. Physics in Medicine and Biology 50 (2005) 2543-2557
243. Manohar S., Vaartjes S.E., van Hespen J.C.G., Klaase J.M., van den Engh F.M., Steenbergen W., and van Leeuwen T.G. Initial results of in vivo non-invasive cancer imaging in the human breast using near-infrared photoacoustics. Optics Express 15 19 (2007) 12277-12285
244. Mar M.V., et al. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. Journal of Nuclear Medicine Technology 35 1 (2007) 10-16
245. Marchetti S., and Schellens J.H. The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. British Journal of Cancer 97 (2007) 577-581
246. Mardor, Y., 2003. Proceedings of the American Association for Cancer Research 41 (abstract 2547).
247. Mariani G., et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. Journal of Nuclear Medicine 42 (2001) 1198-1215
248. Martínez-Möller A., et al. An approach for MR-based attenuation correction for combined MR/PET: effects of ignoring bones. Journal of Nuclear Medicine 48 Suppl. 2 (2007) 156P
249. Maskell N., Gleeson F., and Davies R. CT-guided biopsy for diagnosis of malignant disease in pleural effusions. Lancet 362 (2003) 174
250. Masuzaki R., et al. Assessing liver tumor stiffness by transient elastography. Hepatology International 1 3 (2007) 394-397
251. Matoba M., et al. Lung carcinoma: diffusion-weighted MR imaging - preliminary evaluation with apparent diffusion coefficient. Radiology 243 2 (2007) 570-577
252. Matsuki M., et al. Diffusion-weighed MR imaging of pancreatic carcinoma. Abdominal Imaging 32 4 (2007) 481-483
253. Matsuki M., et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. European Radiology 17 1 (2007) 201-204
254. McDannold N., Moss M., Killiany R., et al. MRI-guided focused ultrasound surgery in the brain: tests in a primate model. Magnetic Resonance in Medicine 49 6 (2003) 1188-1191
255. McDermott G.M., Welch A., Staff R.T., et al. Monitoring primary breast cancer throughout chemotherapy using FDG-PET. Breast Cancer Research and Treatment 102 (2007) 75-84
256. 3He. Magnetic Resonance in Medicine 59 1 (2007) 14-18
257. McKnight A.L., et al. MR elastography of breast cancer: preliminary results. AJR American Journal of Roentgenology 178 (2002) 1411-1417
258. Melodelima D., et al. Using intraluminal ultrasound for the treatment of esophageal tumors: first clinical results. Ultrasonics Symposium 2006 IEEE (2006) 740-743
259. Mercadante S., et al. CT-guided neurolytic splanchnic nerve block by an anterior approach. Journal of Pain and Symptom Management 23 4 (2002) 268-270
260. Meyer B., et al. Contrast-enhanced abdominal angiographic CT for intra-abdominal tumor embolization: a new tool for vessel and soft tissue visualization. Cardiovascular and Interventional Radiology 30 (2007) 743-749
261. Miller J.C., Pien H.H., Sahani D., Sorensen A.G., and Thrall J.H. Imaging angiogenesis: applications and potential for drug development. Journal of the National Cancer Institute 97 (2005) 172-187
262. Minami K. Computerized characterization of contrast enhancement patterns for classifying pulmonary nodules. Proceedings of 2001 International Conference on Image Processing vol. 2 (2001) 897-900
263. Min-Ho L., Nammalvar V., Gobin A., Barton J., West J., and Drezek R. Nanoshells as contrast agents for scatter-based optical imaging. 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro (2006) 371-374
264. Mintun M.A., Welch M.J., Siegel B.A., et al. Breast cancer: PET imaging of estrogen receptors. Radiology 169 (1988) 45-48
265. Miyanaga N., Akaza H., Yamakawa M., Oikawa T., Sekido N., Hinotsu S., Kawai K., Shimazui T., and Shiina T. Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report. International Journal of Urology 13 12 (2006) 1514-1518
266. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer 83 (1998) 245-253
267. Moffat B.A., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proceedings of the National Academy of Sciences USA 102 (2005) 5524-5529
268. Morris E. Breast cancer. In: Edelman R., Hesselink J., and Zlatkin M. (Eds). Clinical Magnetic Resonance Imaging (2006), Elsevier Publishing, Philadelphia, PA 2426-2454
269. Mulder W.J.M., et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Letters 6 (2006) 1-6
270. 18F labeled annexin V: a PET tracer for apoptosis imaging. European Journal of Nuclear Medicine and Molecular Imaging 31 4 (2004) 469-474
271. Muthupillai R., Lomas D.J., Rossman P.J., Greenleaf J.F., Manduca A., and Ehman R.L. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269 (1995) 1854-1857
272. Narayan P., et al. The role of transrectal ultrasound-guided based-staging, preoperative prostate serum antigen, and biopsy Gleason score in prediction of final pathologic diagnosis of prostate cancer. Urology 46 2 (1995) 205-212
273. Nelson E.D., Slotoroff C.B., Gomella L.G., and Halpern E.J. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology 70 6 (2007) 1136-1140
274. Nelson J.L., Roeder B.L., Carmen J.C., Roloff F., and Pitt W.G. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Research 62 (2002) 7280-7283
275. Nelson S.J., et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. Journal of Magnetic Resonance Imaging 7 (1997) 1164-1152
276. Neuwalt E.A., et al. Imaging of iron oxide nanoparticles with MR and light microscopy in patients with malignant brain tumors. Neuropathology and Applied Neurobiology 5 (2004) 456-471
277. Neves A.A., and Brindle K.M. Assessing responses to cancer therapy using molecular imaging. Biochimica Biophysica Acta 1766 (2006) 242-261
278. Ning R., et al. In: Flynn M.J., and Hsieh J. (Eds). Medical Imaging 2006: Physics of Medical Imaging. Proceedings of the SPIE vol. 6142 (2006) 348-356
279. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Annals of Thoracic Surgery 80 (2005) 2020-2025
280. Ntziachristos V., Yodh A.G., Schnall M.D., and Chance B. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 4 4 (2002) 347-354
281. Nunes L.W. Architectural-based interpretations of breast MR imaging. Magnetic Resonance Imaging Clinics of North America 9 2 (2001) 303-320
282. O'Connor M.K., Phillips S.W., Hruska C.B., et al. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast Journal 13 1 (2007) 3-11
283. Ohtani T., Kurihara H., Ishiuchi S., Saito N., Oriuchi N., Inoue T., and Sasaki T. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. European Journal of Nuclear Medicine 28 (2001) 1664-1670
284. Okada A., Murakami T., Mikami K., Onishi H., Tanigawa N., and Marukawa T. Nakamura H. A case of hepatocellular carcinoma treated by MR guided focused ultrasound ablation with respiratory gating. Magnetic Resonance in Medical Sciences 5 3 (2006) 167-171
285. Oraevsky A.A., et al. Optoacoustic imaging of blood for visualization and diagnostics of breast cancer. Proc. SPIE 4618 (2002) 81-94
286. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. Journal of Nuclear Medicine 44 4 (2003) 549-555
287. Paajanen H. Increasing use of mammography improves the outcome of breast cancer in Finland. The Breast Journal 12 1 (2006) 88-90
288. Padhani A.R., and Leach M.O. Antivascular cancer treatments: functional assessments by dynamic contrast enhanced MRI. Abdominal Imaging 30 (2005) 324-341
289. Padhani A.R., et al. . Changes in tumour vascular permeability with antiangiogenesis therapy: observations on histogram analysis. Proceedings of the Eighth International Society of Magnetic Resonance in Medicine, April 3-7, 2000 (2000), Denver. ISMRM, Berkeley, CA 108
290. Padhani A.R., et al. Response of breast carcinoma to chemotherapy: MR permeability changes using histogram analysis. Proceedings of the Eighth International Society of Magnetic Resonance in Medicine, April 3-7, 2000 (2000), Denver. ISMRM, Berkeley, CA 2160
291. ®: Intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. The Breast 16 (2007) 17-26
292. Paliwal S., Sundaram J., and Mitragotri S. Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound. British Journal of Cancer 92 3 (2005) 499-502
293. Pallwein L., Mitterberger M., Struve P., Pinggera G., Horninger W., Bartsch G., Aigner F., Lorenz A., Pedross F., and Frauscher F. Real-time elastography for detecting prostate cancer: preliminary experience. BJU International 100 1 (2007) 42-46
294. Palmeri M., et al. Acoustic radiation force impulse (ARFI) imaging of the gastrointestinal tract. Ultrasonics Symposium 2004 IEEE vol. 1 (2004) 744-747
295. Pappo I., Horne T., Weissberg D., Wasserman I., and Orda R. The usefulness of MIBI scanning to detect underlying carcinoma in women with acute mastitis. Breast Journal 6 (2000) 126-129
296. 11C]Loperamide as highly sensitive PETprobe for measuring changes in P-glycoprotein functional. Journal of Labelled Compounds and Radiopharmaceuticals 46 (2003) S403
297. Pech M., et al. Synchronous CT-guided brachytherapy in patients at risk for incomplete interstitial laser ablation of liver malignancies. Medical Laser Application 19 2 (2004) 78-32
298. Pham C., Roberts T., van Bruggen N., Melnyk O., Mann J., Ferrara N., et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Investigation 16 (1998) 225-230
299. Piao D., et al. Near-infrared optical tomography: endoscopic imaging approach. Proc. SPIE 6431 (2007) 643103-1-643103-10
300. Pierce D.A., Shimizu Y., Preston D.L., et al. Studies of the mortality of atomic bomb survivors: report 12, Part 1 - Cancer: 1950-1990. Radiation Research 146 (1996) 1-27
301. Pineda A.R., et al. Optimization of a tomosynthesis system for the detection of lung nodules. Medical Physics 33 5 (2006) 1372-1379
302. Pisano E.D., et al. Digital Mammographic Imaging Screening Trial (DMIST) investigators group. Diagnostic performance of digital versus film mammography for breast-cancer screening. New England Journal of Medicine 353 17 (2005) 1773-1783
303. Plewes D.B., Bishop J., Samani A., and Sciarretta J. Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography. Physics in Medicine and Biology 45 (2000) 1591-1610
304. Pogue B.W., Poplack S.P., McBride T.O., Wells W.A., Osterman K.S., Osterberg U.L., and Paulsen K.D. Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 218 (2001) 261-266
305. Poplack S.P., et al. Electromagnetic breast imaging: average tissue property values in women with negative clinical findings. Radiology 231 2 (2004) 571-580
306. Poplack S.P., et al. Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. Radiology 243 2 (2007) 350-359
307. Provenzale J.M., Wang G.R., Brenner T., Petrella J.R., and Sorensen A.G. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MRI. AJR American Journal of Roentgenology 178 (2002) 711-716
308. Provenzale J.M., Mukundan S., and Barboriak D. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 239 (2006) 632-649
309. Rabin O., Manuel Perez J., Grimm J., et al. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nature Materials 5 (2006) 118-122
310. Rafferty A.E. Digital mammography: novel applications. Radiologic Clinics of North America 45 5 (2007) 831-843
311. Rago T., et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. Journal of Clinical Endocrinology & Metabolism 92 8 (2007) 2917-2922
312. Rajendran J.G., et al. Hypoxia imaging-directed radiation treatment planning. European Journal of Nuclear Medicine and Molecular Imaging 33 Suppl. 1 (2006) 44-53
313. Rallan D., Dickson M., Bush N.L., Harland C.C., Mortimer P., and Bamber J.C. High-resolution ultrasound reflex transmission imaging and digital photography: potential tools for the quantitative assessment of pigmented lesions. Skin Research and Technology 12 1 (2006) 50-59
314. Rapoport N.Y., Christensen D.A., Fain H.D., Barrows L., and Gao Z. Ultrasound-triggered drug targeting of tumors in vitro and in vivo. Ultrasonics 42 (2004) 943-950
315. Rapoport N., et al. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. Journal of the National Cancer Institute 99 14 (2007) 1095-1106
316. Raylman R.R., et al. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Physics in Medicine and Biology 53 (2008) 637-653
317. Reeves A.P. The Lung Image Database Consortium (LIDC): a comparison of different size metrics for pulmonary nodule measurements. Academic Radiology 14 12 (2007) 1475-1485
318. Rhodes D.J., O'Connor M.K., Phillips S.W., et al. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clinic Proceedings 80 1 (2005) 24-30
319. Ricke J., et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. International Journal of Radiation Oncology Biology Physics 58 5 (2004) 1496-1505
320. Rinneberg H., et al. Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo. Technology in Cancer Research & Treatment 4 5 (2005) 483-496
321. 18F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Annals of Thoracic Surgery 81 (2006) 1076-1081
322. Ro R.J., et al. Assessing angiogenesis in murine glioma and breast tumor models with contrast enhanced ultrasound imaging. Ultrasonics Symposium 2006 IEEE (2006) 416-419
323. 18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning. Journal of Clinical Endocrinology and Metabolism 91 (2006) 498-505
324. Robinson M.K., et al. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Research 65 4 (2005) 1471-1478
325. Rogers W.J., Meyer C.H., and Kramer C.M. Technology insight: in vivo cell tracking by use of MRI. Nature Clinical Practice. Cardiovascular Medicine 3 10 (2006) 554-562
326. Ross R.J., Thompson J.S., Kim K., and Bailey R.A. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. Radiology 143 (1982) 195-205
327. Rossi C.R., et al. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian multicentric study (SOLISM-IMI). Journal of Nuclear Medicine 47 (2006) 234-241
328. 18F]fluorodeoxyglucose positron emission tomography. Journal of Clinical Oncology 24 (2006) 5366-5372
329. Sãftoiu A., and Vilman P. Endoscopic ultrasound elastography - a new imaging technique for the visualization of tissue elasticity distribution. Journal of Gastrointestinal and Liver Diseases 15 2 (2006) 161-165
330. Salomir R., et al. Image-based control of the magnetic resonance imaging-guided focused ultrasound thermotherapy. Topics in Magnetic Resonance Imaging 17 3 (2006) 139-151
331. Samei E., et al. Multiprojection correlation imaging for improved detection of pulmonary nodules. AJR American Journal of Roentgenology 188 (2007) 1239-1245
332. Sampalis F.S., Denis R., Picard D., et al. International prospective evaluation of scintimammography with technetium sestamibi. American Journal of Surgery 185 (2003) 544-549
333. Sandblom G., et al. Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy. Urology 67 5 (2006) 996-1000
334. 14C-Nelfinavir mesylate solution and oral Nelfinavir to healthy volunteers. Journal of Clinical Pharmacology 45 (2005) 1198-1205
335. Sarkeala T., et al. Breast cancer mortality with varying invitational policies in organised mammography. British Journal of Cancer 98 (2008) 641-645
336. Schellenberger E.A., et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Molecular Imaging 1 (2002) 102-107
337. Schoder H., Noy A., Gonen M., et al. Intensity of 18-F fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology 23 (2005) 4643-4651
338. Scholz M., et al. Vibrography during tumor neurosurgery. Journal of Ultrasound in Medicine 24 (2005) 985-992
339. Shah S.K. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features. Academic Radiology 12 10 (2005) 1310-1319
340. Shim S.S., Lee K.S., Kim B., Lee E.J., Choi J.Y., and Chung M.J. Accuracy of integrated PET/CT using fluorodeoxyglucose in preoperative staging on non-small cell lung cancer: a prospective comparison with standalone CT. Radiology 233 (2004) 383 abstract SSE04-02
341. Shulkin B.L., Wienland D.M., Shapiro B., and Sisson J.C. PET epinephrine studies of pheochromocytoma. Journal of Nuclear Medicine 36 (1995) 229P
342. Shulkin B.L., et al. Current concepts on the diagnostic use of MIBG in children. Journal of Nuclear Medicine 39 (1998) 679-688
343. Silverman S.G., et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217 (2000) 657-664
344. Simon C., and Dupuy D. Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. Seminars in Musculoskeletal Radiology 10 (2006) 137-144
345. Sinkus R., Lorenzen J., Schrader D., Lorenzen M., Dargatz M., and Holz D. High-resolution tensor MR elastography for breast tumour detection. Physics in Medicine and Biology 45 (2000) 1649-1664
346. Slovis T.L. Conference on the ALARA (as low as reasonably achievable) concept in pediatric CT: intelligent dose reduction. Pediatric Radiology 32 (2002) 217-218
347. Smith J.J., Sorensen A.G., and Thrall J.H. Biomarkers in imaging: realizing radiology's future. Radiology 227 3 (2003) 633-638
348. 18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nuclear Medicine and Biology 30 (2003) 317-326
349. Souvatzoglou M., Grosu A.L., Roper B., et al. Tumour hypoxia imaging with[(18)F]FAZA PET in head and neck cancer patients: a pilot study. European Journal of Nuclear Medicine Molecular Imaging 34 (2007) 1566-1575
350. Srinivas P.R., Barker P., and Srivastava S. Nanotechnology in early detection of cancer Laboratory Investigation 82 (2002) 657-662
351. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging for axillary lymph node staging - initial findings. European Radiology 16 10 (2006) 2153-2160
352. Stattaus J., et al. CT guided biopsy of small liver lesions: visibility, artifacts and corresponding diagnostic accuracy. Cardiovascular and Interventional Radiology 30 5 (2007) 928-935
353. Steffen A.C., Wikman M., Tolmachev V., et al. In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biotherapy & Radiopharmaceuticals 20 (2005) 239-248
354. Stroobants S., et al. (18)FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). European Journal of Cancer 39 (2003) 2012-2020
355. Su H., Bodenstein C., Dumont R., et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clinical Cancer Research 12 (2006) 5659-5667
356. Su M.Y., et al. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magnetic Resonance in Medicine 39 2 (1998) 259-269
357. Su M.-Y., Taylor J.A., Villarreal L.P., and Nalcioglu O. Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magnetic Resonance Imaging 18 (2000) 311-317
358. Suh Y., Weiss E., and Keall P. A deliverable 4D IMRT planning method for DMLC tumor tracking delivery. International Journal of Radiation Oncology Biology Physics 69 3 (2007) S190-S191
359. 18F]FMAU and positron emission tomography in patients with cancer. European Journal of Nuclear Medicine Molecular Imaging 32 1 (2005) 15-22
360. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. Journal of Nuclear Medicine 44 (2003) 1962-1969
361. Suyash K., et al. Percutaneous computed tomography-guided core biopsy for the diagnosis of mediastinal masses. Annals of Thoracic Medicine 3 1 (2008) 13-17
362. Suzuki K., Li F., Sone S., and Doi K. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network. Medical Imaging 24 9 (2005) 1138-1150
363. Sweeney K.J., and Sacchini V. Is there a role for magnetic resonance imaging in a population-based breast cancer screening program?. Breast Journal 13 6 (2007) 543-544
364. Swensen S.J. Functional CT: Lung nodule evaluation. RadioGraphics 20 (2000) 1178-1181
365. Swensen S.J., et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 226 3 (2003) 756-761
366. Tachibana K., et al. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Letters 149 (2000) 189-194
367. 11C-verapamil. Journal of Nuclear Medicine 47 (2006) 1427-1433
368. Takayoshi U., et al. Dynamic contrast enhanced screening of microcalcifications in the breast. Is there any value?. Breast Cancer Research and Treatment 103 3 (2007) 269-281
369. Tam A., and Ahra K. Palliative interventions for pain in cancer patients. Seminars in Interventional Radiology 24 4 (2007) 419-429
370. Tardivon A.A., Ollivier L., El Khoury C., and Thibault F. Monitoring therapeutic efficacy in breast carcinomas. European Radiology 16 (2006) 2549-2558
371. Tata D.B., et al. Selective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cell lines: LnCap and PC-3. Biochemical and Biophysical Research Communications 234 1 (1997) 64-67
372. Tatum JL, Hoffman JM. Congressional update-report from the biomedical imaging program of the National Cancer Institute-imaging drug development. Academic Radiology 7: 1007-1008 (2000).
373. Taylor S., et al. CT colonography: investigation of the optimum reader paradigm by using computer-aided detection software. Radiology 246 2 (2008) 463-471
374. Tedeschi G., et al. Increased choline signal corresponding to malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. Journal of Neurosurgery 87 (1997) 516-524
375. Teeuwisse W.M., et al. Patient and staff dosage during CT guided biopsy, drainage and coagulation. British Journal of Radiology 74 884 (2001) 720
376. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., Verweij J., Van Glabbeke M., van Oosterom A.T., Christian M.C., and Gwyther S.G. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute 92 3 (2000) 205-216
377. 18F]-FMISO PET data to analyse tumour hypoxia. Physics in Medicine and Biology 50 (2005) 2209-2224
378. Tillmann L., et al. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. World Journal of Urology 22 5 (2004) 357-360
379. 11C. Radiology 230 2 (2004) 423-428
380. Tromberg B.J., et al. Noninvasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2 (2000) 26-40
381. Tromberg B.J., et al. Non-invasive measurements of breast tissue optical properties using frequency-domain photon migration. Philosophical Transactions of the Royal Society of London B 352 (1997) 661-668
382. Tsutsumi M., Miyagawa T., Matsumura T., Kawazoe N., Ishikawa S., Shimokama T., Shiina T., Miyanaga N., and Akaza H. The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis. International Journal of Clinical Oncology 12 4 (2007) 250-255
383. Turetschek K., Preda A., Floyd E., et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. European Journal of Nuclear Medicine and Molecular Imaging 30 (2003) 448-455
384. US Food and Drug Administration. Guidance for Industry, Investigators, and Reviewers. Exploratory IND Studies. Center for Drug Evaluation and Research (2006), US Department of Health and Human Services, Washington, DC 1-16
385. van der Ploeg I.M.C., et al. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. Journal of Nuclear Medicine 48 11 (2007) 1756-1760
386. van Wamel A., Bouakaz A., Bernard B., ten Cate F., and de Jong N. Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics 42 (2004) 903-906
387. 68Ga bioconjugates with high specific radioactivity. Bioconjugate Chemistry 15 (2004) 554-560
388. Vielvoye-Kerkmeer A.P.E. CT guided neurolytic splanchnic nerve block. Journal of Pain and Symptom Management 24 5 (2002) 455
389. Virmani S., et al. Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. Journal of Vascular and Interventional Radiology 18 10 (2007) 1305-1309
390. Vogl T.J. Prostate cancer: MR imaging-guided galvanotherapy - technical development and first clinical results. Radiology 245 3 (2007) 895-902
391. Volterrani L., et al. Three-dimensional analysis of pulmonary nodules by MSCT with Advanced Lung Analysis (ALA1) software. La Radiologia medica 111 3 (2006) 343-354
392. von Rahden B., Sarbia M., and Stein H. Combined FDG-PET/CT and CT-guided biopsy in diagnosing oesophageal cancer recurrence. Journal of the New Zealand Medical Association 119 (2006) 1228
393. 11C-choline PET and PSA values in patients with prostate cancer and biochemical relapse after primary treatments. 2007 ASCO Annual Meeting Proceedings. Journal of Clinical Oncology 25 18S (2007) 5073
394. 18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging 33 6 (2006) 669-672
395. Wald L.L., et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. Journal of Neurosurgery 87 (1997) 525-534
396. Wallace M.J. C-arm computed tomography for guiding hepatic vascular intervention. Techniques in Vascular and Interventional Radiology 10 1 (2007) 79-86
397. Wallace M.J., et al. Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. Journal of Vascular and Interventional Radiology 18 12 (2007) 1500-1507
398. Wang L.V., and Wu H.I. Biomedical Optics (2007), Wiley-Interscience
399. Weichert J., et al. Radioiodinated NM404 - a universal tumor imaging agent?. Academic Radiology 12 5 (2005) S58-S59
400. Weller G.E.R., et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Research 65 (2005) 533-539
401. Wells P., West C., Jones T., et al. Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidine. Biochimica Biophysica Acta 1705 (2004) 91-102
402. Wheatley M.A., Forsberg F., Dube N., Patel M., and Oeffinger B.E. Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound in Medicine & Biology 32 (2006) 83-93
403. Wieder H.A., et al. Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. European Journal of Nuclear Medicine and Molecular Imaging 34 12 (2007) 1925-1932
404. 11C-choline PET-CT for diagnosis of local recurrence following PSA increase after radical prostatectomy: implications for radiotherapy. ASCO 2007 Prostate Cancer Symposium, abstract 178.
405. 11C]-tyrosine and PET. Journal of Nuclear Medicine 36 (1995) 411-419
406. Williams D.B., et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 44 (1999) 720-726
407. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience. Nuclear Medicine Communications 28 5 (2007) 359-363
408. Wong C.Y., Schmidt J., Bong J.S., et al. Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging. Radiation Oncology 2 (2007) 18
409. Wong SH, et al. Capacitive micromachined ultrasonic transducers for high intensity focused ablation of upper abdominal tumors. Ultrasonics Symposium 2006 IEEE, pp. 841-844 (2006).
410. Wong T.Z., et al. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology. AJR American Journal of Roentgenology 184 2 (2005) 676-680
411. Wu A.M., Yazaki P.J., Tsai S., et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proceedings of the National Academy of Sciences USA 97 (2000) 8495-8500
412. Wu F., et al. Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation. Annals of Surgical Oncology 14 (2007) 1237-1242
413. 99mTc-peptide-peptide nucleic acid-peptide chimeras. Journal of Nuclear Medicine 45 (2004) 2070-2082
414. Xiong T., et al. Incidental lesions found on CT colonography: their nature and frequency. British Journal of Radiology 78 (2005) 22-29
415. Xu M., and Wang L.V. Photoacoustic imaging in biomedicine. Review of Scientific Instruments 77 041101 (2006)
416. Xu Y., and Wang L.V. Rhesus monkey brain imaging through intact skull with thermoacoustic tomography. IEEE Transactions on Ultrasonics. Ferroelectrics and Frequency Control 53 (2006) 542-548
417. Xydeas T., et al. Magnetic resonance elastography of the breast: correlation of signal intensity data with viscoelastic properties. Rofo 40 7 (2005) 412-420
418. 18F-annexin V as a PET imaging agent in an animal model of apoptosis. Journal of Nuclear Medicine 46 (2005) 658-666
419. Yamagami T., et al. Management of pneumothorax after percutaneous CT-guided lung biopsy. Chest 121 (2002) 1159-1164
420. 99mTc- labeled anti-CEA monoclonal antibody CL58. World Journal of Gastroenterology 13 12 (2007) 1841-1846
421. Ye G., et al. A 3D EIT system for breast cancer imaging. 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro (2006) 1092-1095
422. Yee J., et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology 219 3 (2001) 685-692
423. Yeung D.K.W., et al. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 225 (2002) 190-197
424. Yu T., Huang X., Hu K., Bai J., and Wang Z. Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure. Ultrasonics Sonochemistry 11 (2004) 287-291
425. 4-methylthiosemicarbazone). Journal of Nuclear Medicine 47 6 (2006) 989-998
426. Yuan L., et al. Preliminary assessment of one-dimensional MR elastography for use in monitoring focused ultrasound therapy. Physics in Medicine and Biology 52 19 (2007) 5909-5919
427. Zagoria R.J., Hawkins A.D., Clark P.E., et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR American Journal of Roentgenology 183 (2004) 201-207
428. Zaidi H., and Alavi A. Current trends in PET and combined (PET/CT and PET/MR) systems design. PET Clinics 2 (2007) 109-123
429. Zeisel S.H. Choline phospholipids: signal transduction and carcinogenesis. FASEB J 7 (1993) 551-557
430. Zhang E., Laufer J., and Beard P. Backward-mode multiwavelength photoacoustic scanner using a planar Fabry-Perot polymer film ultrasound sensor for high- resolution three-dimensional imaging of biological tissues. Applied Optics 47 4 (2008) 561-577
431. Zhang H.F., et al. In vivo volumetric imaging of subcutaneous microvasculature by photoacoustic microscopy. Optics Express 14 20 (2006) 9317-9322
432. 3 integrin receptor-targeted imaging agent. Applied Radiation and Isotopes 65 1 (2007) 70-78
433. 13N-ammonia. Journal of Neuro-Oncology 78 2 (2006) 145-151
434. 18F-FRGD2. Journal of Nuclear Medicine 47 1 (2006) 113-120
435. 3 PET. Journal of Neurooncology 82 (2007) 305-311
436. Zhao M., Beauregard D.A., Loizou L., Davletov B., and Brindle K.M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature Medicine 7 (2001) 1241-1244
437. Zhi H., et al. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. Journal of Ultrasound in Medicine 26 (2007) 807-815
438. Zippel D.B., and Papa M.Z. The use of MR imaging guided focused ultrasound in breast cancer patients: a preliminary phase one study and review. Breast Cancer 12 (2005) 32-38
439. Zudaire I., et al. Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates. Histology and Histopathology 23 1 (2008) 33-40